Suppressed basal mitophagy drives cellular aging phenotypes that can be reversed by a p62-targeting small molecule
George Kelly,Tetsushi Kataura,Johan Panek,Gailing Ma,Hanna Salmonowicz,Ashley Davis,Hannah Kendall,Charlotte Brookes,Daniel Moscoh Ayine-Tora,Peter Banks,Glyn Nelson,Laura Dobby,Patricia R. Pitrez,Laura Booth,Lydia Costello,Gavin D. Richardson,Penny Lovat,Stefan Przyborski,Lino Ferreira,Laura Greaves,Karolina Szczepanowska,Thomas von Zglinicki,Satomi Miwa,Max Brown,Michael Flagler,John E. Oblong,Charles C. Bascom,Bernadette Carroll,Jóhannes Reynisson,Viktor I. Korolchuk
DOI: https://doi.org/10.1016/j.devcel.2024.04.020
IF: 13.417
2024-06-20
Developmental Cell
Abstract:Summary Selective degradation of damaged mitochondria by autophagy (mitophagy) is proposed to play an important role in cellular homeostasis. However, the molecular mechanisms and the requirement of mitochondrial quality control by mitophagy for cellular physiology are poorly understood. Here, we demonstrated that primary human cells maintain highly active basal mitophagy initiated by mitochondrial superoxide signaling. Mitophagy was found to be mediated by PINK1/Parkin-dependent pathway involving p62 as a selective autophagy receptor (SAR). Importantly, this pathway was suppressed upon the induction of cellular senescence and in naturally aged cells, leading to a robust shutdown of mitophagy. Inhibition of mitophagy in proliferating cells was sufficient to trigger the senescence program, while reactivation of mitophagy was necessary for the anti-senescence effects of NAD precursors or rapamycin. Furthermore, reactivation of mitophagy by a p62-targeting small molecule rescued markers of cellular aging, which establishes mitochondrial quality control as a promising target for anti-aging interventions.
cell biology,developmental biology